The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnosticsMaarten Naesens, Michael Mengel, Candice Roufosse et al.|American Journal of Transplantation|2023Cited by 254
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A. Mayer, Georg A. Böhmig, Elisabeth Puchhammer-Stöckl et al.|New England Journal of Medicine|2024Cited by 151
HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLDHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Philippe L. Furlano et al.|Blood|2022Cited by 44
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammationMatthias Diebold, Georg A. Böhmig, Hannes Vietzen et al.|American Journal of Transplantation|2023Cited by 26
Natural Killer Cell Presence in Antibody-Mediated RejectionMatthias Diebold, Georg A. Böhmig, Evan A. Farkash et al.|Transplant International|2024Cited by 19